Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinfa Du

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2022
A Randomized, Open-Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, a Pilot StudyZhigang Ren, Hong Luo, Zujiang Yu, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2012
β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship studyJinfa Du, Donghui Bao, Byoung-Kwon Chun, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2011
Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methylguanosineAngela M Lam, Christine Espiritu, Eisuke Murakami, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2012
Metabolic activation of the anti-hepatitis C virus nucleotide prodrug PSI-352938Congrong Niu, Tatiana Tolstykh, Haiying Bao, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2010
2'-deoxy-2'-α-fluoro-2'-β-C-methyl 3',5'-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: discovery of PSI-352938P Ganapati Reddy, Donghui Bao, Wonsuk Chang, et al.
Plant Biotechnology Journal|July 14, 2023
Comparative genomics of the medicinal plants Lonicera macranthoides and L. japonica provides insight into genus genome evolution and hederagenin-based saponin biosynthesisXiaojian Yin, Yaping Xiang, Feng-Qing Huang, et al.
Bioorganic & Medicinal Chemistry|January 5, 2019
Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitorDavid Sperandio, Vangelis Aktoudianakis, Kerim Babaoglu, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2022
A Randomized, Open-Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, a Pilot StudyZhigang Ren, Hong Luo, Zujiang Yu, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2012
β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship studyJinfa Du, Donghui Bao, Byoung-Kwon Chun, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2011
Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methylguanosineAngela M Lam, Christine Espiritu, Eisuke Murakami, et al.
Antimicrobial Agents and Chemotherapy|April 25, 2012
Metabolic activation of the anti-hepatitis C virus nucleotide prodrug PSI-352938Congrong Niu, Tatiana Tolstykh, Haiying Bao, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2010
2'-deoxy-2'-α-fluoro-2'-β-C-methyl 3',5'-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: discovery of PSI-352938P Ganapati Reddy, Donghui Bao, Wonsuk Chang, et al.
Plant Biotechnology Journal|July 14, 2023
Comparative genomics of the medicinal plants Lonicera macranthoides and L. japonica provides insight into genus genome evolution and hederagenin-based saponin biosynthesisXiaojian Yin, Yaping Xiang, Feng-Qing Huang, et al.
Bioorganic & Medicinal Chemistry|January 5, 2019
Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitorDavid Sperandio, Vangelis Aktoudianakis, Kerim Babaoglu, et al.
Pageof 4